Press & Announcements
Press & Announcements

Background Malaria is one of the leading causes of illness, death, and lost economic productivity globally. A malaria infection may result in a wide variety of symptoms, ranging from absent or mild symptoms like a headache or a fever to organ failure followed by coma and even death. While the successful scale-up and use of...
Read more
BRUSSELS, Feb. 13, 2018 – The Clinton Health Access Initiative, Inc. (CHAI) has been awarded a Horizon Birth Day Prize by the European Commission and the Bill & Melinda Gates Foundation. CHAI is one of three winners, from among 48 applicants, being recognized for a demonstrated and scalable solution to reduce or prevent death during...
Read more
The 2016 Annual Report highlights CHAI’s programmatic work around the world, thanks to our many dedicated partners and supporters.
Read more
Negotiated pricing agreements have lowered costs and will improve access to quality treatment for people living with HIV New York – A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and middle-income countries...
Read more
National HIV treatment programs are preparing for big shifts in their national treatment guidelines and patient regimens. The World Health Organization’s (WHO) 2016 guidelines included a number of antiretroviral (ARV) medications that are more effective, tolerable and affordable (some of which are now available), in addition to optimal pediatric formulations which improve upon limited treatment...
Read moreCHAI in the News
AI fortunes could bring critical funds to Global Health. The scramble is on.
US approval of cheap, generic HIV prevention shot may boost global rollout
CHAI CEO joins Theory of Change podcast to talk end of HIV, scaling AI for health
- Devex: Ghana’s nutrition reset: from donor dependence to government-owned care
- AP News: Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
- Independent: Children living with HIV ‘not getting treatment needed’ as aid cuts hit services
- STAT News: Global health groups push to make cheap generic versions of an HIV prevention drug sold by Gilead
- Devex: CHAI CEO Dr. Neil Buddy Shah named to Devex Power 50
- New York Times: Philanthropies strike a promising deal to turn back HIV
- The Independent: Inside the battle to end the Aids pandemic in the face of Trump’s cuts
- Devex: ‘We’re not seeing a rebound’: New data shows HIV services not recovering
- Devex: CHAI CEO urges fresh vision for global health amid aid cuts
- New York Times: The global threat of antibiotic resistance
- BBC: Three million child deaths linked to drug resistance, study shows
- Al Jazeera: Why is the world suffering from a penicillin shortage?
- Grist: How do you take clean AC mainstream? This global health organization has some ideas.
- Science: Plans to expand African vaccine production face steep hurdles
For press inquiries contact:
Corina Milic, Director of Communications
press@clintonhealthaccess.org